These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 25921840)

  • 21. Dramatic improvement of clinical and hemodynamic parameters of a heart transplant candidate with sildenafil treatment.
    Gerede DM; Sayın T; Vurgun VK; Akbulut IM; Erol C
    Int J Cardiol; 2015 Apr; 185():148-9. PubMed ID: 25795206
    [No Abstract]   [Full Text] [Related]  

  • 22. Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy.
    Bhatia S; Frantz RP; Severson CJ; Durst LA; McGoon MD
    Mayo Clin Proc; 2003 Oct; 78(10):1207-13. PubMed ID: 14531479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of a cutoff value on echo Doppler analysis to replace right heart catheterization during pulmonary hypertension evaluation in heart transplant candidates.
    Bacal F; de Freitas AF; Moreira LF; Fiorelli AI; Mangini S; Abuhab A; de Lima Oliveira J; Santos RH; Stolf NA; Bocchi EA
    Transplant Proc; 2010 Mar; 42(2):535-8. PubMed ID: 20304186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation?
    Kuppahally SS; Michaels AD; Tandar A; Gilbert EM; Litwin SE; Bader FM
    Am J Cardiol; 2010 Dec; 106(11):1657-62. PubMed ID: 21094370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained improvement of clinical status and pulmonary hypertension in patients with severe heart failure treated with sildenafil.
    Urbanowicz T; Straburzyńska-Migaj E; Katyńska I; Araszkiewicz A; Oko-Sarnowska Z; Grajek S; Jemielity M
    Ann Transplant; 2014 Jul; 19():325-30. PubMed ID: 25007352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
    Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
    Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study.
    Gall H; Sommer N; Milger K; Richter MJ; Voswinckel R; Bandorski D; Seeger W; Grimminger F; Ghofrani HA
    BMC Pulm Med; 2016 Jan; 16():5. PubMed ID: 26753921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled Iloprost and Oral Sildenafil Combination Therapy: Is it a Chance for Heart Transplant Candidacy?
    Kocabeyoglu SS; Kervan U; Emre Sert D; Temizhan A; Demirkan B; Aygun E; Akdi M; Pac M
    Heart Lung Circ; 2020 Jul; 29(7):1039-1045. PubMed ID: 31818725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial.
    Cooper TJ; Cleland JGF; Guazzi M; Pellicori P; Ben Gal T; Amir O; Al-Mohammad A; Clark AL; McConnachie A; Steine K; Dickstein K
    Eur J Heart Fail; 2022 Jul; 24(7):1239-1248. PubMed ID: 35596935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
    Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe pulmonary hypertension associated with COPD: hemodynamic improvement with specific therapy.
    Girard A; Jouneau S; Chabanne C; Khouatra C; Lannes M; Traclet J; Turquier S; Delaval P; Cordier JF; Cottin V
    Respiration; 2015; 90(3):220-8. PubMed ID: 26277885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of sildenafil on cardiac performance in patients with heart failure.
    Hirata K; Adji A; Vlachopoulos C; O'Rourke MF
    Am J Cardiol; 2005 Nov; 96(10):1436-40. PubMed ID: 16275194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy with sildenafil and bosentan reverts severe pulmonary hypertension and allows heart transplantation: case report.
    Mogollón MV; Lage E; Cabezón S; Hinojosa R; Ballesteros S; Aranda A; Sobrino JM; Ordóñez A
    Transplant Proc; 2006 Oct; 38(8):2522-3. PubMed ID: 17097987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health-related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension.
    Liu LC; Hummel YM; van der Meer P; Berger RM; Damman K; van Veldhuisen DJ; Voors AA; Hoendermis ES
    Eur J Heart Fail; 2017 Jan; 19(1):116-125. PubMed ID: 27873388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [SPECIFICS OF INHALED ILOPROST PHARMACODYNAMICS IN PATIENTS WITH SEVERE LEFT VENTRICULAR SYSTOLIC DYSFUNCTION].
    Bautin AE; Iakovlev AS; Tashkhanov DM; Datsenko SV; Marichev AO; Popov MA; Fedotov PA
    Anesteziol Reanimatol; 2015; 60(2):4-7. PubMed ID: 26148353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.
    Sastry BK; Narasimhan C; Reddy NK; Raju BS
    J Am Coll Cardiol; 2004 Apr; 43(7):1149-53. PubMed ID: 15063421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac correlates of exercise induced pulmonary hypertension in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Maréchaux S; Pinçon C; Le Tourneau T; de Groote P; Huerre C; Asseman P; Van Belle E; Nevière R; Bauters C; Deklunder G; Lejemtel TH; Ennezat PV
    Echocardiography; 2008 Apr; 25(4):386-93. PubMed ID: 18177381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.